Stem-cell therapy is valued for its potential to restore damaged or degenerating tissues. Stem cells are now regularly used to renew blood, and it looks as if the next success could be in treating dystrophic muscle.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Notes
This article and the paper concerned1 were published online on 15 November 2006.
References
Sampaolesi, M. et al. Nature 444, 574–579 (2006).
Emery, A. E. Lancet 359, 687–695 (2002).
Chamberlain, J. S. & Rando, T. A. (eds) Duchenne Muscular Dystrophy: Advances in Therapeutics (Taylor & Francis, New York, 2006).
Minasi, M. G. et al. Development 129, 2773–2783 (2002).
Gussoni, E. et al. Nature 401, 390–394 (1999).
Qu-Petersen, Z. et al. J. Cell Biol. 157, 851–864 (2002).
Galvez, B. G. et al. J. Cell Biol. 174, 231–243 (2006).
Gregorevic, P. et al. Nature Med. 12, 787–789 (2006).
Harper, S. Q. et al. Nature Med. 8, 253–261 (2002).
Sampaolesi, M. et al. Science 301, 487–492 (2003).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chamberlain, J. A move in the right direction. Nature 444, 552–553 (2006). https://doi.org/10.1038/nature05406
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature05406
This article is cited by
-
Targeting RNA to treat neuromuscular disease
Nature Reviews Drug Discovery (2011)
